Found 11 matching trials
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
N/AThe primary objective of this study is to evaluate the protective efficacy ...
Status
Active Not Recruiting
Location
Sheyang County Center for Disease Control and Prevention
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
N/AThe primary objective of this study is to evaluate the durability of protec...
Location
Peking University People's Hospital
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
PHASE4The purpose of this study is to evaluate the immunogenicity and safety of R...
Location
Yuecheng Center for Disease Control and Prevention
Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
PHASE1This phase I clinical study was designed to evaluate the safety of novel re...
Location
Jiangsu Provincial Centre for Disease Control and Prevention
The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
N/AThe primary objective of this study is to evaluate the durability of protec...
Location
Henan Cancer Hospital
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
PHASE4This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
PHASE3This is a bridging trial of the recombinant HPV 16/18 bivalent vaccine manu...
Location
Jiangsu Provincial Centre for Disease Control and Prevention
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
PHASE3This phase III clinical study was designed to evaluate the efficacy,immunog...
Status
Active Not Recruiting
Location
Jiangsu Provincial Centre for Disease Control and Prevention
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
PHASE3This is a Phase III clinical trial of the novel recombinant HPV 16/18 bival...
Location
Cancer Institute & Hospital Chinese Academy of Medical Sciences
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
N/AThe primary objective of this study is to evaluate the immuno-persistence (...
Location
Jiangsu Provincial Centre for Disease Control and Prevention